BioXcel Therapeutics
BTAI
#9513
Rank
A$40.53 M
Marketcap
$0.99
Share price
2.37%
Change (1 day)
-86.48%
Change (1 year)

BioXcel Therapeutics (BTAI) Fails to deliver data

Key failure to deliver metrics for BioXcel Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for BioXcel Therapeutics (BTAI) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for BioXcel Therapeutics (BTAI) - since 2018

Volume in USD (price x number of shares), data since 2018

BioXcel Therapeutics (BTAI) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024A$25.18 M-67.15%
2023A$76.65 M331.84%
2022A$17.75 M36.6%
2021A$12.99 M-3.8%
2020A$13.5 M120.5%
2019A$6.12 M54.66%
2018A$3.96 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
A$1.42 MA$6.01 M๐Ÿ‡บ๐Ÿ‡ธ USA